EMCURE:NSE
Emcure Pharmaceuticals Ltd
₹ २,३४८.००
arrow_upward
+१.४५%(+३३.६०) 1D
नोभेम्बर १३, १५:३०:०० GMT+५:३० · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EMCURE...
Open
₹ २,३२५.००
High
₹ २,३९५.००
Low
₹ २,३१५.४०
Mkt. cap
४.४७ खरब
Avg. vol.
२.२९ लाख
Volume
२.९५ लाख
Dividend
०.१५%
Quarterly dividend
₹ ०.९०
Ex-dividend date
२०२६ सेप्टेम्बर ४
P/E ratio
४९.२९
52-wk high
₹ २,४२९.९०
52-wk low
₹ १,३१२.३०
EPS
₹ ४७.६४
No. of employees
७ हजार
Open
₹ २,३२५.००
High
₹ २,३९५.००
Low
₹ २,३१५.४०
Mkt. cap
४.४७ खरब
Avg. vol.
२.२९ लाख
Volume
२.९५ लाख
Dividend
०.१५%
Quarterly dividend
₹ ०.९०
Ex-dividend date
२०२६ सेप्टेम्बर ४
P/E ratio
४९.२९
52-wk high
₹ २,४२९.९०
52-wk low
₹ १,३१२.३०
EPS
₹ ४७.६४
No. of employees
७ हजार
News stories
From web sources and news partners
TradingKey
·
४७ मिनेट पहिले
S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months
TradingView
·
७ घण्टा पहिले
SpaceX's S&P 500 bid gets new life as Elon Musk pitches Tesla merger
24/7 Wall St.
·
३ घण्टा पहिले
He Thinks His $200,000 S&P 500 401(k) Spreads His AI Risk. Two Alphabet Share Classes Put $10,380 in One Company. A 20% Drop Could Cost Him $2,076
Traders Union
·
७ घण्टा पहिले
Michael Kantro: Institutional investors focus on stock picking as S&P 500 targets have lost relevance
Profile
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals. Wikipedia
About Emcure Pharmaceuticals Ltd
CEOSatish Ramanlal Mehta
Employees६.९१ हजार
Founded१९८१ अप्रिल १६
Headquarters-
SectorHealth Care
Industry-
Websiteemcure.com